#GileadNews: We’ve signed non-exclusive, royalty-free voluntary licensing agreements to enable access to our investigational medication for #HIV prevention across 120 high-incidence, resource-limited countries, if approved. The agreements reflect our ongoing commitment to providing rapid, broad and sustainable access to our medicines and to improving health equity across the globe. Learn more: https://gilead.inc/3Bw8AlB
Gilead Sciences
Biotechnology Research
Foster City, CA 646,025 followers
Creating Possible
About us
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Website
-
http://www.gilead.com
External link for Gilead Sciences
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Foster City, CA
- Type
- Public Company
- Founded
- 1987
Locations
Employees at Gilead Sciences
Updates
-
For more than 35 years, we’ve translated cutting-edge science into innovative solutions, advanced our commitment to achieve health equity and delivered life-changing medicines to people all over the world. Explore our newly redesigned website to see the strides we’ve made: https://www.gilead.com/ #GileadLife
Explore Our Newly Redesigned Website
-
“We’re less than six years away from the United Nations’ goal of eliminating HIV by 2030, yet no country in the world is close to that goal.” Authors of a new report, commissioned by Gilead, found that there are treatment and tools available to help end the HIV epidemic, but every country in the world – no matter rich or poor – has much more to do to make it happen. Learn why. https://gilead.inc/4dnAoG9
-
We’re happy to share that Deborah Telman, EVP, Corporate Affairs and General Counsel, received the Legislative Award from The Black Women's Agenda (BWA). Founded in 1979, BWA is devoted to advancing, securing and protecting the rights of women by working collaboratively with 43 national and international women’s organizations. Deb received the honor in recognition of the initiatives she’s led at Gilead and beyond to make a difference in global communities, including Black women and their families. With more than 25 years of executive leadership experience, Deb has built a career grounded in service and continues to be a champion for health equity. Past Legislative Award recipients include Dr. Maya Angelou, Secretary Condoleezza Rice, The Honorable Kamala Harris and Dr. Johnnetta Cole.
-
Extraordinary progress toward ending the #HIV epidemic can be possible when leaders from around the world work together. That was the theme of a UNAIDS panel at the 79th United Nations General Assembly where Daniel O'Day, Gilead Chairman and Chief Executive Officer, took to the stage. Dan shared the company’s longstanding efforts to transform the treatment and prevention landscape for HIV and its ongoing work to ensure its medications translate to impact for populations around the world. “Through scientific innovation, collaboration and putting people at the center, we will do everything possible to make our shared goal of ending AIDS a reality,” he said. The Global Fund #UNGA79
-
Reflecting on #ESMO24 and #WCLC24, Gilead’s Amy Otto shared her perspective on how these gatherings foster collaboration and creativity, helping us write the next chapters to transform the way cancer is treated. Read more: https://gilead.inc/3MTNccr
-
During Gilead’s recent Science Day, we caught up with a few of our talented and passionate researchers. Get to know some of the people responsible for turning cutting-edge science into life-changing medicines for people around the world. #PassThePhoneChallenge
-
Prompt and accurate diagnoses are the first step toward treatment access and improved clinical outcomes. On #WorldPatientSafetyDay, we’re joining patients, healthcare workers, policymakers and the World Health Organization to help improve diagnoses globally and to protect the health and safety of all people.
-
As we celebrate #HispanicHeritageMonth, we’re proud to have signed the Hispanic Promise, reaffirming our commitment to the Hispanic community. Fostering a diverse workforce and inclusive environment drives innovation and helps build a more equitable future for all. This pledge is embedded in our talent development, recruitment practices and supplier diversity. #GileadLife
-
At #2024USCHA, we gather with advocates dedicated to ending the HIV epidemic. The Gilead COMPASS Initiative® plays a critical role in reducing health disparities and stigma in the U.S. South. Watch to learn more about our grantee EAGLE Pass Safe and the work they’re doing to raise awareness of HIV in Texas: https://gilead.inc/4gs01bl
Affiliated pages
Similar pages
Browse jobs
Stock
GILD
NASDAQ
20 minutes delay
$84.59
0.42 (0.499%)
- Open
- 84.34
- Low
- 83.98
- High
- 84.96
Data from Refinitiv
See more info on